Ultragenyx Pharmaceutical Inc. buy The Goldman Sachs Group, Inc.
Start price
02.08.24
/
50%
€46.20
Target price
02.08.25
€69.62
Performance (%)
-46.75%
End price
03.08.25
€24.60
Summary
This prediction ended on 03.08.25 with a price of €24.60. Massive losses of -46.75% were the result for the BUY prediction by The_Goldman_Sachs_Gr. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | -0.503% | -0.503% | -51.232% |
| iShares Core DAX® | 3.002% | 3.742% | 24.169% |
| iShares Nasdaq 100 | 2.966% | 1.308% | 9.141% |
| iShares Nikkei 225® | 5.606% | 4.472% | 21.237% |
| iShares S&P 500 | 2.312% | 1.880% | 6.333% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $67.00 to $76.00. They now have a "buy" rating on the stock.
Ratings data for RARE provided by MarketBeat
In the thread Trading Ultragenyx Pharmaceutical Inc.
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten
Stopped prediction by The_Goldman_Sachs_Gr for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€40.80
06.06.24
06.06.24
€61.55
06.06.25
06.06.25
-21.08%
07.06.25
07.06.25
